| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/16/2007 | CN1964986A Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 05/16/2007 | CN1964741A Methods of using molecules related to organic cation transporter 3 (OCT3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 05/16/2007 | CN1964740A Methods and compositions for treating and preventing diseases associated with alphaVbeta5 integrin |
| 05/16/2007 | CN1964739A Uses of anti-CTLA-4 antibodies |
| 05/16/2007 | CN1964738A Monoclonal antibodies to hepatocyte growth factor |
| 05/16/2007 | CN1964630A Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 05/16/2007 | CN1962694A Antibody for detecting chlamydia pneumoniae |
| 05/16/2007 | CN1316248C Analytical sandwich assay for the determination of NT-proBNP |
| 05/16/2007 | CN1315537C LIM Mineralization protein splice variants |
| 05/15/2007 | US7217819 Immobilization of taxane; anticancer, antitumor agents |
| 05/15/2007 | US7217811 Human gene critical to fertility |
| 05/15/2007 | US7217802 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine |
| 05/15/2007 | US7217801 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products |
| 05/15/2007 | US7217800 Peptide leukotriene receptor |
| 05/15/2007 | US7217799 Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancer |
| 05/15/2007 | US7217798 has an increased (or decreased) in vivo half-life by virtue of the presence of a modified IgG constant domain (preferably from a human IgG), or FcRn-binding portion thereof (preferably the Fc or hinge-Fc domain) |
| 05/15/2007 | US7217797 Engineered immunoglobulins for use in immunodiagnostics and/or therapeutics |
| 05/15/2007 | US7217796 Neutralizing human anti-IGFR antibody |
| 05/15/2007 | US7217795 Tumor suppressor designated TS10q23.3 |
| 05/15/2007 | US7217792 an antibody reactive with the isolated polypeptide induces proliferation of peripheral blood lymphocytes in the presence of an antibody reactive with CD3; used to treat autoimmune diseases and allergic diseases |
| 05/15/2007 | US7217791 a polypeptide conjugated to a Streptococcus pneumoniae capsular polysaccharide; an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity; vaccine; genetic vaccine; antigen |
| 05/15/2007 | US7217788 Controlling immunology; antiinflammatory agents |
| 05/15/2007 | US7217786 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 05/15/2007 | US7217718 Administering an immunosuppressant; therapy for autoimmune disease |
| 05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
| 05/15/2007 | US7217693 Human G protein-coupled receptor expressed in the dorsal root ganglia |
| 05/15/2007 | US7217575 Avidin derivatives and uses thereof |
| 05/15/2007 | US7217565 Contacting, binding to monoclonal antibodies; therapy for central nervous system disorders |
| 05/15/2007 | US7217535 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 05/15/2007 | US7217529 antibody binds to polypeptide which is a member of the chemokine family; diagnostic methods for detecting disorders related to the immune system |
| 05/15/2007 | US7217528 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/15/2007 | US7217416 Use of gamma globulin for the topical treatment of lesions of dermatitis |
| 05/15/2007 | US7217415 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use |
| 05/15/2007 | US7217412 IL-17C related mammalian cytokine polypeptides |
| 05/15/2007 | CA2332131C Serine protease-specific monoclonal antibody and utilization thereof |
| 05/15/2007 | CA2255540C Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/15/2007 | CA2249736C Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2165672C Antibodies specific for human prostate glandular kallikrein |
| 05/15/2007 | CA2156397C Rapamycin assay |
| 05/15/2007 | CA2149922C Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 05/15/2007 | CA2130452C Altered antibodies, products and processes relating thereto |
| 05/15/2007 | CA2094705C Pharmaceutical composition for treating or preventing malign tumors |
| 05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 05/15/2007 | CA2071879C Glutamate receptor compositions and methods |
| 05/15/2007 | CA2065414C Treatment of autoimmune disease |
| 05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
| 05/10/2007 | WO2007053781A2 Compositions with antigens adsorbed to calcium phosphate |
| 05/10/2007 | WO2007053718A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 05/10/2007 | WO2007053524A2 Horse: human chimeric antibodies |
| 05/10/2007 | WO2007052242A1 Composition and method for the treatment of viral infection using camelid heavy chain antibodies |
| 05/10/2007 | WO2007052067A2 Von willebrand factor (vwf) binding peptides |
| 05/10/2007 | WO2007051836A2 Compositions for treating dermatological and neurological disorders |
| 05/10/2007 | WO2007051805A2 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 05/10/2007 | WO2007051781A1 Novel cxc-chemokine antagonists |
| 05/10/2007 | WO2007051623A1 Affiphores, their isolation and use |
| 05/10/2007 | WO2007014169A3 Anti-cd26 antibodies and methods of use thereof |
| 05/10/2007 | WO2007011873A3 Method for treating intraocular neovascular diseases |
| 05/10/2007 | WO2007007173A3 Human anti-madcam antibodies |
| 05/10/2007 | WO2007002096A3 Methods and compositions for targeting ifnar2 |
| 05/10/2007 | WO2006133148A3 Method of producing antibodies with modified fucosylation level |
| 05/10/2007 | WO2006132445A3 A pharmaceutical composition for treating and diagnosing a disorder associated with peroxisomal biogenesis and function |
| 05/10/2007 | WO2006131512A3 Anti-thrombotic agents |
| 05/10/2007 | WO2006118959A3 Antibodies directed against amyloid-beta peptide and methods using same |
| 05/10/2007 | US20070106070 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell |
| 05/10/2007 | US20070106069 Non-Human Primate Fc Receptors and Methods of Use |
| 05/10/2007 | US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders |
| 05/10/2007 | US20070106067 Assay kit and antibody for human low molecular weight cd14 |
| 05/10/2007 | US20070106065 TAT- 001 and methods of assessing and treating cancer |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105777 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/10/2007 | US20070105771 Anti-CD26 antibodies and methods of use thereof |
| 05/10/2007 | US20070105225 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 05/10/2007 | US20070105218 Lupus antibodies for passive immunotherapy of hiv/aids |
| 05/10/2007 | US20070105211 Optical fiber array device capable of simultaneously performing multiple functional assays |
| 05/10/2007 | US20070105199 Methods for generating monovalent IgG |
| 05/10/2007 | US20070105198 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents; drug screening |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105171 Human Protease Molecules |
| 05/10/2007 | US20070105169 Secreted polypeptide species associated with cardiovascular disorders |
| 05/10/2007 | US20070105164 Cancer diagnosis and therapy |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105149 Assay for diabetes |
| 05/10/2007 | US20070105148 Sphingosine 1-phosphate receptor gene, SPPR |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/10/2007 | US20070105092 Proteolytic and covalent antibodies |
| 05/10/2007 | US20070104739 Equine protozoal myeloencephalitis vaccine |
| 05/10/2007 | US20070104731 Helicobacter proteins and vaccines |
| 05/10/2007 | US20070104724 Attaching substances to microorganisms |
| 05/10/2007 | US20070104722 Targeted biocides |
| 05/10/2007 | US20070104720 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/10/2007 | US20070104719 Caspase Activated Prodrugs Therapy |
| 05/10/2007 | US20070104716 Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin |
| 05/10/2007 | US20070104715 Alzheimer's disease, systemic amyloidosis and other amyloid disorders; kits |
| 05/10/2007 | US20070104713 Nogo receptor homologs |
| 05/10/2007 | US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors |
| 05/10/2007 | US20070104711 Using tumor necrosis factor inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders |
| 05/10/2007 | US20070104710 Immunoglobulin variable domain; competitive binding; treating allergic hypersensitivity, asthma |
| 05/10/2007 | US20070104709 Non-naturally occurring ligand for umami taste and sweet taste receptor; enhancing response to artificial flavoring |